[1]
Mendoza, L. 2018. Clinical development of RET inhibitors in RET-rearranged non-small cell lung cancer: Update. Oncology Reviews. 12, 2 (Jul. 2018). DOI:https://doi.org/10.4081/oncol.2018.352.